Calyxo Announces FDA Clearance for New, Redesigned CVAC System
Calyxo, Inc. , a medical device company developing innovative solutions for patients with kidney stones, announced that it has received FDA clearance for its new, redesigned CVAC System, which enables a minimally invasive approach to kidney stone treatment.
- Calyxo, Inc. , a medical device company developing innovative solutions for patients with kidney stones, announced that it has received FDA clearance for its new, redesigned CVAC System, which enables a minimally invasive approach to kidney stone treatment.
- More than 50 procedures have already been completed by 12 urologists with the new CVAC System, yielding strong patient outcomes and consistently positive physician feedback.
- Based on learnings from over two years of real-world use, Calyxo reimagined its CVAC System to further enhance the SURE procedure.
- “CVAC” and “Calyxo” are registered trademarks of Calyxo, Inc.